Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/46998
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorFERNANDES, Alan L.-
dc.contributor.authorREIS, Bruna Z.-
dc.contributor.authorMURAI, Igor H.-
dc.contributor.authorPEREIRA, Rosa M. R.-
dc.date.accessioned2022-06-20T15:24:10Z-
dc.date.available2022-06-20T15:24:10Z-
dc.date.issued2022-
dc.identifier.citationFRONTIERS IN NUTRITION, v.9, article ID 802562, 9p, 2022-
dc.identifier.issn2296-861X-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/46998-
dc.description.abstractPurposeTo evaluate whether the prognostic nutritional index (PNI) is related to the oxygen therapy requirement at hospital admission and to ascertain the prognostic effect of the PNI and the oxygen therapy requirement as predictors of hospital length of stay in patients with moderate to severe coronavirus disease 2019 (COVID-19). MethodsThis is a post-hoc analysis in hospitalized patients with moderate to severe COVID-19. The participants were categorized: (1) non-oxygen therapy (moderate COVID-19 not requiring oxygen therapy); (2) nasal cannula therapy (severe COVID-19 requiring nasal cannula oxygen therapy); and (3) high-flow therapy (severe COVID-19 requiring high-flow oxygen therapy). PNI was calculated for each patient according to the following equation: serum albumin [g/dL] x 10 + total lymphocyte count [per mm(3)] x 0.005. The participants were categorized into malnutrition (PNI <40), mild malnutrition (PNI 40-45), and non-malnutrition (PNI > 45). ResultsAccording to PNI, malnutrition was more prevalent in the high-flow therapy group (94.9%; P < 0.001) with significantly lower PNI compared to both groups even after adjusting for the center and C-reactive protein. Patients in the high-flow therapy group [9 days (95% CI 7.2, 10.7), P < 0.001] and malnutrition status [7 days (95% CI 6.6, 7.4), P = 0.016] showed a significant longer hospital length of stay compared to their counterparts. The multivariable Cox proportional hazard models showed significant associations between both oxygen therapy requirement and PNI categories and hospital discharge. ConclusionIn addition to oxygen therapy requirement, low PNI was associated with longer hospital length of stay. Our findings suggest that PNI could be useful in the assessment of nutritional status related to the prognosis of patients with moderate to severe COVID-19.eng
dc.language.isoeng-
dc.publisherFRONTIERS MEDIA SAeng
dc.relation.ispartofFrontiers in Nutrition-
dc.rightsopenAccesseng
dc.subjectSARS-CoV-2 infectioneng
dc.subjectCOVID-19eng
dc.subjectmalnutritioneng
dc.subjectprognosiseng
dc.subjectnutritional statuseng
dc.subjectassessmenteng
dc.subjectprognostic nutritional index (PNI)eng
dc.subject.othermortalityeng
dc.subject.othersurvivaleng
dc.subject.othermarkereng
dc.subject.otherriskeng
dc.titlePrognostic Nutritional Index and Oxygen Therapy Requirement Associated With Longer Hospital Length of Stay in Patients With Moderate to Severe COVID-19: Multicenter Prospective Cohort Analyseseng
dc.typearticleeng
dc.rights.holderCopyright FRONTIERS MEDIA SAeng
dc.identifier.doi10.3389/fnut.2022.802562-
dc.identifier.pmid35479742-
dc.subject.wosOncologyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalREIS, Bruna Z.:Fac Med Univ Sao Paulo, Hosp Clin HCFMUSP, Rheumatol Div, Sao Paulo, Brazil; Univ Fed Rio Grande do Norte, Ctr Hlth Sci, Dept Nutr, Natal, Brazil-
hcfmusp.description.articlenumber802562-
hcfmusp.description.volume9-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000791592400001-
hcfmusp.origem.id2-s2.0-85128987557-
hcfmusp.publisher.cityLAUSANNEeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceAnker MS, 2021, J CACHEXIA SARCOPENI, V12, P9, DOI 10.1002/jcsm.12674eng
hcfmusp.relation.referenceCheng YL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004876eng
hcfmusp.relation.referenceCinar T, 2021, HEART LUNG, V50, P307, DOI 10.1016/j.hrtlng.2021.01.006eng
hcfmusp.relation.referenceDe Lorenzo A, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02464-zeng
hcfmusp.relation.referenceDi Filippo L, 2021, CLIN NUTR, V40, P2420, DOI 10.1016/j.clnu.2020.10.043eng
hcfmusp.relation.referenceDoganci S, 2020, EUR REV MED PHARMACO, V24, P10247, DOI 10.26355/eurrev_202010_23249eng
hcfmusp.relation.referenceFernandes AL, 2022, AM J CLIN NUTR, V115, P790, DOI 10.1093/ajcn/nqab426eng
hcfmusp.relation.referenceFransson E, 2008, J CLIN EPIDEMIOL, V61, P840, DOI 10.1016/j.jclinepi.2007.09.004eng
hcfmusp.relation.referenceGrimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1eng
hcfmusp.relation.referenceGucu A, 2021, REV CARDIOVASC MED, V22, P499, DOI 10.31083/j.rcm2202057eng
hcfmusp.relation.referenceHazra A, 2017, INDIAN J DERMATOL, V62, P251, DOI 10.4103/ijd.IJD_201_17eng
hcfmusp.relation.referenceHiesmayr M, 2012, CURR OPIN CLIN NUTR, V15, P174, DOI 10.1097/MCO.0b013e328350767eeng
hcfmusp.relation.referenceHu X, 2021, NUTRITION, V84, DOI 10.1016/j.nut.2020.111123eng
hcfmusp.relation.referenceHuang JF, 2020, J MED VIROL, V92, P2152, DOI 10.1002/jmv.26003eng
hcfmusp.relation.referenceJeon HG, 2016, ANN SURG ONCOL, V23, P321, DOI 10.1245/s10434-015-4614-0eng
hcfmusp.relation.referenceKos M, 2016, EUR GERIATR MED, V7, P13, DOI 10.1016/j.eurger.2015.07.007eng
hcfmusp.relation.referenceLi MY, 2020, NUTR METAB CARDIOVAS, V30, P1061, DOI 10.1016/j.numecd.2020.04.013eng
hcfmusp.relation.referenceLuan CW, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96598-9eng
hcfmusp.relation.referenceMurai IH, 2021, JAMA-J AM MED ASSOC, V325, P1053, DOI 10.1001/jama.2020.26848eng
hcfmusp.relation.referenceNational Institutes of Health (NIH), 2021, ANT THER COVID 19 TReng
hcfmusp.relation.referenceMartinuzzi ALN, 2021, NUTR HOSP, V38, P1119, DOI 10.20960/nh.03749eng
hcfmusp.relation.referenceOnodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001eng
hcfmusp.relation.referencePeng YD, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016796eng
hcfmusp.relation.referenceRashedi S, 2021, NUTR CLIN PRACT, V36, P970, DOI 10.1002/ncp.10750eng
hcfmusp.relation.referenceReis BZ, 2021, AM J CLIN NUTR, V114, P598, DOI 10.1093/ajcn/nqab151eng
hcfmusp.relation.referenceShi YJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257425eng
hcfmusp.relation.referenceSong FE, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00702-8eng
hcfmusp.relation.referenceTang YQ, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025127eng
hcfmusp.relation.referenceVavruk AM, 2021, NUTR CLIN PRACT, V36, P993, DOI 10.1002/ncp.10637eng
hcfmusp.relation.referenceWang ZH, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.582736eng
hcfmusp.relation.referenceXue GH, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107065eng
hcfmusp.relation.referenceZhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3eng
dc.description.indexPubMedeng
hcfmusp.citation.scopus0-
hcfmusp.scopus.lastupdate2022-09-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - COVID-19
COVID-19

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia

Artigos e Materiais de Revistas Científicas - ODS/02
ODS/02 - Fome zero e agricultura sustentável

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Artigos e Materiais de Revistas Científicas - ODS/09
ODS/09 - Indústria, inovação e infraestrutura


Files in This Item:
File Description SizeFormat 
art_FERNANDES_Prognostic_Nutritional_Index_and_Oxygen_Therapy_Requirement_Associated_2022.PDFpublishedVersion (English)388.23 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.